Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Inhibition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT06081153
What this trial is testing

Mechanistic Clinical Trial of PCSK9 Inhibition for AAA

Who this might be right for
Abdominal Aortic Aneurysm
University of Pennsylvania 44
Early research (Phase 1)Study completedNCT02845037
What this trial is testing

Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453

Who this might be right for
HypertensionChronic Heart Failure
Bial - Portela C S.A. 80
Not applicableUnknownNCT06000345
What this trial is testing

Effect of Action Observation and Motor Imagery on Arthrogenic Muscle Inhibition of the Quadriceps in Patients With End-stage Knee Gonarthrosis.

Who this might be right for
Knee OsteoarthritisArthrogenic Muscle Inhibitions
Istituto Clinico Humanitas 30
Testing effectiveness (Phase 2)Study completedNCT03649724
What this trial is testing

The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Weill Medical College of Cornell University 86
Early research (Phase 1)WithdrawnNCT03066115
What this trial is testing

Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow Regulation

Who this might be right for
HypoxiaHypercapnia
University of Wisconsin, Madison
Early research (Phase 1)Active Not RecruitingNCT04470024
What this trial is testing

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Who this might be right for
Cancer of the Head and Neck
Providence Health & Services 19
Not applicableStudy completedNCT07096076
What this trial is testing

The Immediate Effects Of Thoracolumbar Fascia Inhibition And Suboccipital Muscle Inhibition

Who this might be right for
Healthy Individuals With Hamstring Tightness
Bulent Ecevit University 75
Testing effectiveness (Phase 2)Study completedNCT06331624
What this trial is testing

Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisIPF
GRI Bio Operations, Inc. 35
Post-approval studies (Phase 4)Study completedNCT00469690
What this trial is testing

Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects

Who this might be right for
Cataract
Innovative Medical 58
Testing effectiveness (Phase 2)Study completedNCT01204190
What this trial is testing

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

Who this might be right for
Contraception
Bayer 173
Testing effectiveness (Phase 2)Study completedNCT03311555
What this trial is testing

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

Who this might be right for
Prostate Cancer
Andrew J. Armstrong, MD 39
Testing effectiveness (Phase 2)Study completedNCT00181155
What this trial is testing

Intravenous Allopurinol in Heart Failure

Who this might be right for
Congestive Heart Failure
Johns Hopkins University 18
Early research (Phase 1)Study completedNCT04739774
What this trial is testing

Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 24
Very early researchUnknownNCT02749513
What this trial is testing

Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

Who this might be right for
Esophageal Cancer
Dallas VA Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT03648489
What this trial is testing

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Carcinosarcoma+7 more
Imperial College London 134
Not applicableStudy completedNCT00046215
What this trial is testing

Transcranial Magnetic Stimulation to Study Imagination of Movement

Who this might be right for
Healthy
National Institute of Neurological Disorders and Stroke (NINDS) 20
Post-approval studies (Phase 4)Study completedNCT03331289
What this trial is testing

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

Who this might be right for
Diabetes Mellitus, Type 2
The University of Texas Health Science Center at San Antonio 107
Testing effectiveness (Phase 2)Study completedNCT03102047
What this trial is testing

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

Who this might be right for
Rectal Cancer
NSABP Foundation Inc 45
Not applicableLooking for participantsNCT07152925
What this trial is testing

The Impact of Beta-band Transcranial Alternating Current Stimulation (tACS) on Impulse Inhibition in Adolescents With Non-suicidal Self-injury

Who this might be right for
Depression DisordersNon-suicidal Self-injury
Anhui Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT03785210
What this trial is testing

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI) 22
Next Page